Should we perform routine psa testing in all patients over 50 years of age?

Article Sidebar

PDF (Spanish)
Published: 2018-06-30
DOI: https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v38i2.580
Keywords:
Ask the Expert

Main Article Content

Alejandro Carbone Zárate
Sección Oncología Clínica, Servicio de Clínica Médica Hospital Italiano de Buenos Aires, Argentina

Abstract

A healthy 55-year-old man with no family history of prostate disease and no urinary symptoms comes to the clinic for a routine check-up and blood tests. Should we perform routine PSA testing in all patients over 50 years of age?

Downloads

Download data is not yet available.

Article Details

Issue

Vol. 38 No. 2 (2018): Revista del Hospital Italiano de Buenos Aires

Section

Ask the expert
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

How to Cite

1.
Carbone Zárate A. Should we perform routine psa testing in all patients over 50 years of age?. Rev Hosp Ital B.Aires [Internet]. 2018 Jun. 30 [cited 2026 Apr. 27];38(2):85-6. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/580

References

Vertosick EA, Poon BY, Vickers AJ. Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening. J Urol. 2014;192(3):724-728. DOI: https://doi.org/10.1016/j.juro.2014.03.032

National Comprehensive Cancer Network [Internet]. Fort Washington, PA: NCCN; 2018 [consulta 06/08/2018]. Disponible en: https://www.nccn.org

De Vita VT, Lawrence TS, Rosenberg SA, eds. Principles and practice of oncology. 8th ed. Philadelphia: Lippincott Wiliams & Wilkins; 2008. 2 v.

Ilic D, Neuberger MM, Djulbegovic M, y col. Screening for prostate cancer. Cochrane Database Syst Rev. 2013;(1):CD004720. DOI: https://doi.org/10.1002/14651858.CD004720.pub3

Eastham J, Vickers A, Lilja H, et al. Prostate cancer screening guidelines [internet]. New York: Memorial Sloan Kettering Cancer Center; [2018] [consulta 06/08/2018]. Disponible en: https://www.mskcc.org/cancer-care/types/prostate/screening/screening-guidelines-prostate

United States Preventive Services Task Force. Prostate cancer screening final recommendation [Internet]. Rockville, MD: USPSTF; 2018 [consulta 06/08/2018]. Disponible en: https://screeningforprostatecancer.org/

Martin RM, Donovan JL, Turner EL, et al. Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial. JAMA. 2018;319(9):883-895. DOI: https://doi.org/10.1001/jama.2018.0154

Cosma G, McArdle SE, Reeder S, et al. Identifying the presence of prostate cancer in individuals with PSA levels <20 ng ml(-1) using computational data extraction analysis of high dimensional peripheral blood flow cytometric phenotyping data. Front Immunol. 2017;8:1771.Conflictos de interés: el autor declara no tener conflictos de interés. DOI: https://doi.org/10.3389/fimmu.2017.01771